Figure 2From: Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisCML and CEL plasma levels in DMT-naïve MS patients and MS patients treated with DMTs. Comparison of Plasma levels of CML (A) and CEL (B) in DMT-naïve MS patients and patients on DMTs, stratified by gender. The results are means ± SEM. P value ≤ 0.05 is statistically significant. Abbreviations as in Table 1, and DMT:disease modifying therapy.Back to article page